Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)

Teerlink, J. et al. (2005) Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). American Heart Journal, 150, pp. 46-53. (doi:10.1016/j.ahj.2005.04.035)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Teerlink, J., McMurray, J., Bourge, R., Cleland, J., Cotter, G., Jondeau, G., Krum, H., Metra, M., O'Connor, C., Parker, J., Torre-Amione, G., van Veldhuisen, D., Frey, A., Rainisio, M., Kobrin, I., and Investigators, V.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:American Heart Journal

University Staff: Request a correction | Enlighten Editors: Update this record